influenza
break
everi
year
caus
sever
infect
respiratori
system
novel
influenza
pandem
erupt
north
america
caus
death
vaccin
antivir
drug
main
method
prevent
control
influenza
variat
influenza
viru
applic
vaccin
sever
circumscrib
current
therapeut
strategi
influenza
includ
ion
channel
inhibitor
neuraminidas
inhibitor
broadspectrum
antivir
rna
polymeras
inhibitor
amantadin
oseltamivir
zanamivir
main
ion
channel
inhibitor
neuraminidas
inhibitor
remark
effect
influenza
viru
infect
report
increasingli
resist
develop
new
drug
drug
combin
focus
medicin
ribavirin
rbv
triazol
compound
nucleosid
analog
rna
polymeras
inhibitor
rbv
wellcharacter
broadspectrum
antivir
drug
variou
rna
dna
virus
includ
influenza
influenza
b
virus
approv
dovepress
dovepress
lin
et
al
american
food
drug
administr
treatment
influenza
viru
respiratori
syncyti
viru
infect
nebul
inhal
hepat
c
viru
infect
combin
interferon
nanomateri
studi
appli
carrier
drug
biomed
field
special
physic
chemic
properti
compar
normal
materi
small
particl
size
contribut
stabl
nanostructur
enabl
easi
entranc
cell
report
silver
nanoparticl
load
paclitaxel
enhanc
apoptosi
cancer
cell
compar
paclitaxel
alon
gold
nanoparticl
use
deliv
chemotherapeut
drug
research
studi
remark
properti
includ
high
surfaceareatovolum
ratio
surfac
plasmon
reson
forth
mesopor
silica
nanoparticl
load
doxorubicin
exhibit
higher
intracellular
drug
releas
cancer
cell
compar
element
selenium
nanoparticl
senp
characterist
viru
infect
first
selenium
statu
may
affect
function
cell
innat
adapt
immun
report
selenium
defici
suppos
relat
viru
infect
includ
coxsacki
viru
human
immunodefici
viru
selenium
supplement
healthi
human
adult
margin
selenium
statu
result
benefici
detriment
effect
cellular
immun
flu
caus
influenza
viru
sodium
selenit
suppress
hepat
b
viru
transcript
replic
vitro
furthermor
senp
use
induc
robust
cytokin
pattern
hepat
b
viru
vaccin
besid
senp
show
dengu
viru
activ
depress
cytopath
effect
previou
studi
prove
senp
load
oseltamivir
amantadin
respect
inhibit
apoptosi
induc
influenza
viru
infect
vitro
report
virus
induc
apoptosi
activ
primari
execution
program
cell
death
directli
indirectli
respons
cleavag
mani
protein
caspas
involv
apoptosi
activ
cleav
two
protein
fragment
cleav
respons
proteolyt
cleavag
mani
critic
protein
rbv
carri
senp
make
new
nanoparticl
drug
system
enter
cell
effect
antivir
activ
influenza
viru
nano
system
detect
via
cell
viabil
assay
viral
titer
test
vitro
follow
lung
injuri
detect
final
relationship
antivir
activ
apoptot
pathway
explor
vitro
vivo
experi
madindarbi
canin
kidney
mdck
cell
bought
american
type
cultur
collect
manassa
va
usa
influenza
viru
donat
guangzhou
institut
respiratori
diseas
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
gain
thermo
fisher
scientif
waltham
usa
chloromethyl
keton
tpck
thiazolyl
blue
tetrazolium
bromid
mtt
na
seo
ascorb
acid
vc
rbv
lyso
tracker
dapi
sigmaaldrich
co
st
loui
mo
usa
use
studi
onestep
revers
transcript
polymeras
chain
reaction
rtpcr
kit
acquir
takara
kyoto
japan
primer
probe
synthet
sangon
biotech
shanghai
peopl
republ
china
activ
assay
kit
tunel
detect
kit
purchas
beyotim
jiangsu
peopl
republ
china
cleav
cleav
polyadpribos
polymeras
parp
phosphoryl
bax
phosphoryl
phosphoryl
junaminotermin
kinas
pjnk
monoclon
antibodi
suppli
cell
signal
technolog
danver
usa
dimethylbenzen
hydrogen
peroxid
h
dab
mount
medium
bought
gbcbio
technolog
guangdong
peopl
republ
china
ml
na
seo
solut
ml
mm
vc
solut
drop
ml
ultrapur
water
stir
minut
rbv
ad
follow
dialysi
hour
concentr
se
rbv
detect
use
induct
coupl
plasmaatom
emiss
spectrometri
senp
se
rbv
sampl
store
morpholog
se
rbv
observ
transmiss
electron
microscopi
tem
element
composit
se
rbv
detect
energydispers
xray
spectroscopi
edx
size
distribut
zeta
potenti
se
rbv
determin
zetas
analyz
restrict
influenza
viru
infect
selenium
nanoparticl
load
co
mdck
cell
infect
influenza
viru
tissu
cultur
infect
dose
tcid
calcul
brief
cell
plate
hour
adsorb
viru
hour
supernat
replac
dmem
contain
tpcktreat
trypsin
tcid
calcul
use
reedmuench
method
viru
use
vitro
studi
titer
tcid
ml
tcid
ml
vivo
experi
cytotox
se
rbv
detect
mtt
assay
mdck
cell
infect
viru
treat
senp
rbv
se
rbv
contain
senp
rbv
respect
hour
mtt
solut
ad
final
concentr
mgml
hour
solut
well
suck
away
hour
later
dimethyl
sulfoxid
ad
absorb
valu
record
nm
minut
later
rna
level
viru
test
rtpcr
rna
extract
amplif
perform
onestep
rtpcr
kit
primer
follow
forward
primer
ctcagcaaatcctacatta
revers
primer
tagtagatggatggtgaat
sequenc
probe
ccatagcacgaggacttctt
gapdh
forward
primer
cgccaagaaggtgatcatttc
revers
primer
caggaggcgttcgagatgac
mdck
cell
cultur
dish
treat
lyso
tracker
minut
dapi
label
se
rbv
ad
variou
time
period
incub
imag
analyz
analyz
fluoresc
microscop
activ
mensur
use
activ
detect
kit
cell
lyse
radioimmunoprecipit
assay
buffer
lysat
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
band
polyvinyliden
difluorid
membran
immunoblot
primari
antibodi
includ
cleav
cleav
parp
bax
pjnk
monoclon
antibodi
secondari
antibodi
imag
visual
tanon
gel
imag
system
fifteen
femal
balbc
mice
age
week
anim
experi
center
guangdong
provinc
peopl
republ
china
randomli
divid
five
group
physiolog
salin
group
without
infect
treatment
control
mock
group
viru
control
rbv
group
treat
rbv
post
infect
senp
group
treat
senp
se
rbv
group
treat
senp
load
rbv
mice
anesthet
chloral
hydrat
dose
intraperiton
inject
control
group
treat
physiolog
salin
nasal
drip
four
group
treat
viru
tcid
ml
titer
nasal
drip
well
hour
rbv
senp
se
rbv
contain
rbv
nmol
senp
administ
anesthet
mice
respect
via
intranas
absorpt
everi
hour
thereaft
total
three
time
clinic
symptom
mice
observ
mice
execut
cervic
disloc
anesthesia
chloral
hydrat
day
treatment
given
last
lung
extract
affus
physiolog
salin
fix
paraformaldehyd
hematoxylin
eosin
h
e
stain
tunel
test
immunohistochemistri
stain
done
mice
experi
approv
guid
ethic
committe
guangzhou
medic
univers
experiment
anim
center
guangzhou
medic
univers
h
e
stain
tunel
test
immunohistochemistri
lung
fix
paraformaldehyd
hour
dehydr
grade
ethanol
seri
embed
paraffin
section
embed
wax
cut
slice
h
e
stain
tunel
test
immunohistochemistri
tunel
test
slice
label
tunel
reaction
mixtur
dapi
green
fluoresc
stood
posit
immunohistochemistri
slice
dewax
dimethylbenzen
minut
rehydr
alcohol
minut
antigen
retriev
quench
h
block
slice
incub
cleav
cleav
parp
pjnk
antibodi
respect
overnight
follow
incub
secondari
antibodi
color
graphpad
prism
softwar
graphpad
softwar
inc
la
jolla
ca
usa
use
data
analysi
twotail
student
ttest
oneway
analysi
varianc
use
evalu
signific
data
differ
consid
statist
signific
shown
tem
imag
figur
senp
se
rbv
appear
monodispers
spheric
moreov
diamet
senp
nm
se
rbv
nm
size
distribut
figur
confirm
averag
size
se
rbv
senp
nm
nm
respect
decor
rbv
surfac
surfacefre
energi
senp
decreas
nanoparticl
becam
stabl
thu
diamet
se
rbv
smaller
senp
alon
particl
size
se
rbv
contribut
stabl
nanostructur
made
propiti
pass
cytomembran
surfac
element
composit
analysi
carri
edx
figur
reveal
strong
signal
se
atom
c
atom
atom
n
atom
presenc
atom
indic
rbv
conjug
surfac
senp
shown
figur
zeta
potenti
senp
alon
mv
decreas
mv
carri
rbv
explain
higher
stabil
se
rbv
mdck
cell
infect
viru
subsequ
untreat
treat
rbv
senp
se
rbv
cytotox
effect
mdck
cell
detect
mtt
assay
figur
indic
cell
viabil
without
treatment
restrict
influenza
viru
infect
selenium
nanoparticl
load
infect
cell
treat
rbv
senp
achiev
viabil
respect
addit
cell
treat
se
rbv
achiev
signific
viabil
data
indic
antivir
activ
rbv
effect
got
strengthen
coat
senp
rna
level
test
display
figur
cell
treat
se
rbv
infect
got
lowest
titer
level
rbv
senp
alon
suggest
rbv
effect
load
senp
figur
cell
infect
viru
without
treatment
show
enlarg
intercellular
space
cell
swell
lysi
cytopath
effect
weaken
treat
se
rbv
assay
present
se
rbv
effect
resist
prolifer
viru
endocytosi
nanoparticl
signific
transmiss
studi
drug
load
nanosystem
figur
show
green
label
se
rbv
accumul
mdck
cell
membran
move
lysosom
label
red
lyso
tracker
present
yellow
purpl
overlap
site
approxim
minut
later
se
rbv
escap
lysosom
releas
cytoplasm
chen
et
al
report
senp
load
polysaccharid
shuttl
across
cell
membran
hour
accumul
gradual
lysosom
dispers
cytoplasm
result
coincid
studi
detect
suggest
se
rbv
target
lysosom
subsequ
cellular
action
apoptosi
induc
viru
infect
mdck
cell
treat
rbv
senp
se
rbv
viru
infect
activ
detect
express
cleav
cleav
parp
investig
reflect
figur
activ
cell
infect
viru
without
treatment
control
group
cell
uninfect
se
rbvtreat
group
markedli
reduc
compar
rbvtreat
group
senp
group
suggest
viru
probabl
induc
apoptosi
effect
suppress
se
rbv
addit
express
protein
decreas
cleav
cleav
parp
increas
infect
treat
se
rbv
chang
three
turn
weak
result
suggest
se
rbv
inhibit
apoptosi
regul
parp
protein
apoptosi
initi
activ
cleav
apoptosi
execution
cleav
respons
proteolyt
cleavag
mani
critic
protein
parp
cleavag
parp
facilit
cellular
disassembl
serv
marker
apoptosi
could
infer
se
rbv
restrain
apoptosi
pathway
inhibit
activ
mdck
cell
infect
viru
treat
rbv
senp
se
rbv
hour
protein
relat
apoptosi
signal
pathway
detect
mention
earlier
se
rbv
inhibit
mitochondri
apoptosi
bax
play
key
role
apoptosi
mitochondri
stress
enhanc
membran
permeabl
help
activ
caspas
pathway
shown
figur
viru
infect
led
increas
express
bax
protein
treatment
se
rbv
express
downregul
addit
express
ident
variat
tendenc
bax
activ
phosphoryl
activ
affect
apoptosi
regul
bax
gene
activ
transcript
bax
benefit
express
protein
promot
apoptosi
process
phosphoryl
result
suggest
se
rbv
might
regul
express
bax
attenu
express
protein
meanwhil
se
rbv
restrain
figur
regul
bax
resist
activ
inhibit
apoptosi
cell
jnk
signal
could
activ
viru
infect
phosphoryl
jnk
sign
apoptosi
two
protein
investig
studi
display
figur
express
pjnk
increas
cell
infect
viru
without
subsequ
treatment
evid
decreas
follow
treatment
se
rbv
result
reflect
jnk
signal
pathway
took
part
restrict
apoptosi
se
rbv
evalu
effici
se
rbv
influenza
viru
vivo
mice
infect
viru
treat
rbv
senp
se
rbv
follow
h
e
stain
tunel
analys
immunohistochem
test
lung
tissu
execut
figur
mice
infect
viru
without
treatment
tend
reduc
physic
activ
feed
mice
treat
se
rbv
post
infect
present
activ
increas
appetit
h
e
stain
reveal
figur
group
manifest
alveolar
collaps
perivascular
peribronchiolar
edema
compar
control
group
treat
rbv
senp
symptom
lessen
crucial
quit
amaz
se
rbv
attenu
histopatholog
manifest
substanti
result
directli
indic
se
rbv
evid
protect
lung
injur
infect
dna
around
nucleosom
cut
apoptosi
occur
tunel
use
detect
dna
fragment
disrupt
apoptosi
shown
figur
se
rbv
prevent
dna
damag
infect
altogeth
h
e
stain
tunel
analys
illustr
se
rbv
good
effect
lung
injuri
mice
suffer
viru
infect
investig
probabl
mechan
se
rbv
cure
mice
immunohistochem
test
lung
implement
exhibit
figur
cleav
cleav
parp
pjnk
protein
found
posit
viru
infect
nevertheless
treatment
se
rbv
reduc
appear
visibl
result
coincid
previou
vitro
studi
jnk
particip
restrict
viru
infect
se
rbv
load
rbv
broadspectrum
antivir
agent
senp
prepar
simpl
highli
effici
method
senp
modifi
rbv
se
rbv
rescu
cell
apoptosi
induc
influenza
viru
infect
reduc
viru
titer
cultur
supernat
besid
lung
injuri
dna
damag
attenu
se
rbv
treatment
mice
furthermor
activ
signal
pathway
resist
vitro
vivo
restrict
influenza
viru
infect
selenium
nanoparticl
load
experi
conclus
studi
elabor
senp
load
rbv
restrain
apoptosi
induc
influenza
viru
infect
signal
pathway
